OncoImmunology
期刊ISSN: 2162-4011
E-ISSN: 2162-402X
影响因子: 登录后查看数据
自引率: 2.3%
SCI期刊JCR分区
SCI期刊JCR分区等级:1区
按学科分区
IMMUNOLOGY
Q1
ONCOLOGY
Q1
最新中科院SCI期刊分区(基础版)
大类学科
医学
2区
小类学科
免疫学
2区
肿瘤学
2区
Top期刊
综述期刊
最新中科院SCI期刊分区(升级版)
大类学科
医学
2区
小类学科
免疫学
2区
肿瘤学
2区
Top期刊
综述期刊
期刊简介
Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now create a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.
出版信息
出版商
Landes Bioscience
涉及的研究方向
ONCOLOGY-IMMUNOLOGY
年文章数
218
出版国家或地区
UNITED STATES
是否OA
Cite Score相关
Cite Score SJR SNIP 排名
13.3 2.096 1.263
学科
大类学科:Medicine
小类学科:Oncology
分区
Q1
学科
大类学科:Medicine
小类学科:Immunology and Allergy
分区
Q1
学科
大类学科:Medicine
小类学科:Immunology
分区
Q1
SCI期刊投稿推荐
JCR分区相关期刊
中科院分区相关期刊
去登录